Chdromosome aberrations in mice by the antifungal antibiotic, nystatin

Area of Science:

• Pharmacology
• Toxicology
• Cytogenetics

Background:

• Nystatin is a widely used antifungal medication.
• Understanding the genotoxic potential of pharmaceuticals is crucial for patient safety.

Purpose of the Study:

• To investigate the in vivo cytogenetic effects of Nystatin in mouse bone marrow cells.
• To determine the temporal relationship and distribution patterns of Nystatin-induced chromosomal aberrations.

Main Methods:

• Administration of Nystatin to mice.
• Analysis of bone marrow cells for chromosomal aberrations at various time points (15 min to 15 days).
• Statistical evaluation of aberration frequencies and distribution.

Main Results:

• A significant increase in chromosomal aberrations was observed following Nystatin administration.
• The majority of observed aberrations were of the chromatid type.
• Aberrations exhibited a non-random distribution pattern within the chromosomes.

Conclusions:

• Nystatin demonstrates clastogenic activity in vivo, inducing chromosomal damage in mouse bone marrow.
• The findings suggest a need for careful consideration of Nystatin's genotoxic potential in clinical settings.
• Further research into the mechanisms of Nystatin-induced genotoxicity is warranted.